Efficacy and safety of a humanized α4β7 antibody in active crohn's disease (CD)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of a humanized α4β7 antibody in active crohn's disease (CD)

Published:2003-04 Issue:4 Volume:124 Page:A25-A26
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Feagan Brian G.,Greenberg Gordon,Wild Gary,McDonald John W.D.,Fedorak Richard,Pare Pierre,Kishimoto Kei,Gutierrez-Ramos Jose-Carlos,Krop Julie

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introducing Vedolizumab to Clinical Practice: Who, When, and How?;Journal of Crohn's and Colitis;2015-02-16

2. Vedolizumab for induction and maintenance of remission in ulcerative colitis;Cochrane Database of Systematic Reviews;2014-08-08

3. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease;Expert Review of Clinical Immunology;2010-07

4. Targeted Treatments for Inflammatory Bowel Diseases;Inflammatory Bowel Disease;2010-04-26

5. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation;Journal of Cellular Physiology;2010-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP